1. Home
  2. NIKI vs ARTL Comparison

NIKI vs ARTL Comparison

Compare NIKI & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niki BioSolutions Inc. Common Stock

NIKI

Niki BioSolutions Inc. Common Stock

N/A

Current Price

$1.87

Market Cap

1.5M

Sector

Health Care

ML Signal

N/A

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$2.35

Market Cap

1.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NIKI
ARTL
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.4M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
NIKI
ARTL
Price
$1.87
$2.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.7K
★ 32.3K
Earning Date
11-10-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.88
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$0.52
52 Week High
$10.39
$179.19

Technical Indicators

Market Signals
Indicator
NIKI
ARTL
Relative Strength Index (RSI) 22.57 32.73
Support Level N/A $0.52
Resistance Level $5.17 $6.81
Average True Range (ATR) 0.35 0.17
MACD 0.05 0.03
Stochastic Oscillator 8.54 18.33

Price Performance

Historical Comparison
NIKI
ARTL

About NIKI Niki BioSolutions Inc. Common Stock

Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: